The Conventional Transforming Growth Factor- (TGF- ) Receptor Type I Is Not Required for TGF- 1 Signaling in a Human Prostate Cancer Cell Line, LNCaP

By Kim I.Y.   Zelner D.J.   Lee C.  

Experimental Cell Research, Vol. 241, Iss. 1, 1998-05 ,pp. : 151-160

Elsevier

Access to resources Recommend Favorite

P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells

By Ricote M.   García-Tuñón I.   Fraile B.   Fernández C.   Aller P.   Paniagua R.   Royuela M.  

Apoptosis, Vol. 11, Iss. 11, 2006-11 ,pp. : 1969-1975

Springer Publishing Company

Access to resources Recommend Favorite

Modulation of Sensitivity to Transforming Growth Factor- 1 (TGF- 1) and the Level of Type II TGF- Receptor in LNCaP Cells by Dihydrotestosterone

By Kim I.Y.   Zelner D.J.   Sensibar J.A.   Ahn H.-J.   Park L.   Kim J.-H.   Lee C.  

Experimental Cell Research, Vol. 222, Iss. 1, 1996-01 ,pp. : 103-110

Elsevier

Access to resources Recommend Favorite

DIRECT INFLUENCES OF PRO-INFLAMMATORY CYTOKINES (IL-1β, TNF-α, IL-6) ON THE PROLIFERATION AND CELL-SURFACE ANTIGEN EXPRESSION OF CANCER CELLS

By Kuninaka S.   Yano T.   Yokoyama H.   Fukuyama Y.   Terazaki Y.   Uehara T.   Kanematsu T.   Asoh H.   Ichinose Y.  

Cytokine, Vol. 12, Iss. 1, 2000-01 ,pp. : 8-11

Academic Press

Access to resources Recommend Favorite

-Lapachone-Induced Apoptosis in Human Prostate Cancer Cells: Involvement of NQO1/xip3

By Planchon S.M.   Pink J.J.   Tagliarino C.   Bornmann W.G.   Varnes M.E.   Boothman D.A.  

Experimental Cell Research, Vol. 267, Iss. 1, 2001-07 ,pp. : 95-106

Elsevier

Access to resources Recommend Favorite